61 results found

Russia has a lively pharmaceutical market, in which it is possible to obtain comprehensive patent protection for products and methods that are aimed at treating and diagnosing specific diseases.

Import substitution (a significant increase of the share of medicines and medical devices of Russian origin) in the pharmaceutical and medical industries is envisaged by...

The basic provisions of the Recommendations that are worth to pay attention to are discussed below.

When patenting inventions in Russia, one potential route is granting a patent for an invention relating to a well-known product used for a new purpose, the so-called ‘second medical use invention'.

On October 29, 2018, the Government of the Russian Federation approved the changes

Therapeutic Use Exemptions (TUEs) first hit the headlines back in 2016 when Russian hackers released medical information about athletes who had applied for such exemptions from the International Olympic Committee (the "IOC").

This year events relating to global pandemics of COVID-19 for sure had impact on various issues of human civilization.

The pharmaceutical industry is currently one of the Russian economy's high-tech development priorities. According to analytical data, in 2019 the Russian commercial drug market was worth Rb84.3 billion (approximately...

On December 15, 2020, in the first reading, the Russian State Duma approved amendments to Article 1360 of the Civil Code "Use of an Invention, Utility Model or Industrial Design in the Interests of...

According to official statistics, the pharmaceutical industry in Russia was among the industries that showed maximum growth in 2020.

The Russian government has introduced a risk-oriented approach for scheduled inspections in the healthcare industry

Россия в рамках ЕАЭС создаст единый реестр фармакологически активных веществ, охр

Until January 1, 2017, for confirming the state registration of a foreign medicinal product, it is permitted to present a certificate of GMP compliance to the applicable GMP standards in the country of origin...

Until January 1, 2017, for confirming the state registration of a foreign medicinal product, it is permitted to present a certificate of GMP compliance to the applicable GMP standards in the country of origin.

The Federal Law dated 22 December 2014 No. 429-FZ to become effective from 1 July 2015, introduces important amendments to the Federal Law dated 12 April 2010 No. 61-FZ ‘On Medicines’Circulation’.

Илья Костин, партнер ЮК «Правовой Альянс»

We received information on special representative of the President of Ukraine on child rights procurement of drugs used for the treatment and prevention of diseases in children, with the purpose of checking their quality.